2005

Sep 21, 2005
Guidant Enrolls 300 Patients in Drug Eluting Stent Pivotal Trials and Completes Manufacturing Audit

Successful Inspection Brings Company One Step Closer to European Approval; Drug Eluting Stent Milestone Results in Payment to Novartis in Third Quarter Indianapolis, Ind. - Guidant Corporation...

Sep 19, 2005
Guidant Announces FDA Approval of Wireless Home Patient Management System

Innovative Technology Directed Toward Compliance in Heart Failure Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...

Aug 29, 2005
Guidant Independent Panel Recruited, Begins Deliberations
Aug 25, 2005
Guidant Announces European Clearance of Acquisition

European Commission Ruling Necessitates Organizational and Staffing Adjustments Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that as a result of the European Commission...

Aug 24, 2005
Guidant Receives FDA Approval to Expand U.S. Drug Eluting Stent Trial

Approval Sufficient for Completion of Pivotal Trial Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has received approval from the U.S. Food and Drug...

Show 5102550100 per page
Top